![]() | Up a level |
Amaefule, C. E., Drymoussi, Z., Gonzalez Carreras, F. J. , Pardo Llorente Del Carmen, M., Lanz, D., Dodds, J., Sweeney, L., Pizzo, E., Thomas, A., Heighway, J., Daru, J., Sobhy, S., Poston, L., Khalil, A., Myers, J., Harden, A. ORCID: 0000-0002-8621-5066, Hitman, G., Khan, K. S., Zamora, J., Pérez, T., Huda, M. S. B. & Thangaratinam, S. (2022).
Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study.
BMJ Open, 12(3),
doi: 10.1136/bmjopen-2021-050110
Amaefule, C. E., Bolou, A., Drymoussi, Z. , Gonzalez Carreras, F. J., Pardo Llorente, M. D. C., Lanz, D., Dodds, J., Sweeney, L., Pizzo, E., D'Amico, M., Thomas, A., Heighway, J., Daru, J., Sobhy, S., Robson, J., Sanghi, A., Zamora, J., Harden, A. ORCID: 0000-0002-8621-5066, Hitman, G., Khan, K., Pérez, T., Huda, M. S. B. & Thangaratinam, S. (2020).
Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: a protocol for a randomised, placebo-controlled, double-blind feasibility trial—Optimising health outcomes with Metformin to prevent diAbetes After pregnancy (OMAhA).
BMJ Open, 10,
e036198.
doi: 10.1136/bmjopen-2019-036198